Rebamipide as a Potential Alternative Gastroprotective Agent to Proton Pump Inhibitor in Elderly Chronic Nonsteroidal Anti-Inflammatory Drug Users without Risk Factors.

Int J Gen Med · 2022 · PMC8922238 · PMID 35300126

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

might not be significantno p-value reported

Nonetheless, chronic NSAID users are highly likely to receive prescriptions rather than purchase over-the-counter medication; therefore, the clinical impact underestimated in this study might not be significant.

also in 670 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.